ABSTRACT
INTRODUCTION
Colorectal cancer is currently the third leading cause of cancer-related death worldwide when men and women are considered separately, and the second leading cause when both sexes are combined (1). In 2012, 32,240 new cases of colorectal cancer were diagnosed in Spain, which accounted for 15% of all cancers diagnosed.
Over the same period there were 14,700 colorectal cancer-related deaths (14.7% of all cancer-related deaths), the second highest rate after lung cancer (1).
The effectiveness and the efficiency of colorectal cancer screening have been widely documented, achieving not only early cancer detection but also a reduction in mortality (2, 3) . In 1993, Mandel et al. (4) reported a 33% reduction of cancer-related deaths from colorectal cancer in asymptomatic patients diagnosed via a screening program based on the fecal occult blood test (FOBT) when compared with nonscreened patients. An earlier tumor stage at diagnosis was also demonstrated and since then other studies have confirmed these results (5, 6) . A Cochrane review including these studies and their corresponding updates estimated that the implementation of colorectal cancer screening programs was associated with a reduction in mortality of 16% (7, 8) . The oncological benefits of screening programs have also been demonstrated in those patients undergoing surgery with a curative intent. A recent retrospective study analyzed a cohort of 1,071 patients, 217 of which had been diagnosed via screening by colonoscopy. Patients diagnosed outside the screening program showed higher recurrence rates and a lower disease-free survival and overall survival (11) .
Although the long-term benefits of colorectal cancer screening have been demonstrated extensively, the potential benefits on short-term outcome are unknown. The aim of this study was to assess whether there were differences in the short-term postoperative outcomes between colorectal cancer patients diagnosed via a screening program and those diagnosed elsewhere (outside the program). Table I ).
METHODS

An early detection colorectal cancer program was initiated in
Postoperative ileus was considered when intolerance to diet led to a delay in discharge beyond the seventh postoperative day, the oral intake was interrupted for more than 48 hours or when insertion of a nasogastric tube was necessary.
Statistical analysis
Data from the two study groups (screening group, control group) were analyzed using 
RESULTS
During the study period, 523 patients underwent surgery for a colorectal neoplasm (Fig. 1) . A group of 80 patients were diagnosed via the screening program (screening group) and 106 patients aged between 50 and 69 years were diagnosed outside the program (controls). In the multivariate analysis, diagnosis outside the screening program, type of surgical procedure, open surgery and Charlson comorbidity index were independent risk factors for short-term complications (Table IV) .
DISCUSSION
This study shows that, aside from the already known benefits of screening in the longterm outcomes (increase of disease-free survival and reduction of cancer-related mortality), colorectal cancer screening is associated with better outcomes in the postoperative period (fewer complications and shorter length of hospital stay).
The difference in postoperative morbidity was mainly related to a higher percentage of grade II complications of the Clavien-Dindo classification in the group of patients diagnosed elsewhere and, in particular, to a greater need for perioperative transfusion. In part, this is because the patients in the control group had lower preoperative hemoglobin levels. Other factors such as a greater number of stage I patients and a higher rate of a laparoscopic approach in the screening group (although not statistical significant) could have had an impact on the reduced need for transfusion. On the other hand, perioperative transfusion is an independent risk factor for a worse oncological outcome (13, 14) .
The nutritional status is a key factor in cancer patients undergoing surgery (15) . The serum albumin is a simple estimation of the visceral protein and is one of the best parameters to assess the nutritional condition. Several studies have found an association between serum albumin concentration and in-hospital mortality (16) (17) (18) , postoperative complications (18, 19) , duration of hospitalization (18, 20) , quality of life (21) and prognosis in cancer patients (22) (23) (24) (25) . Patients from the screening program had a better nutritional status based on preoperative serum albumin levels. It is important to note that 15% of patients in the control group presented hypoalbuminemia compared with zero patients in the screening group. Even though the control group showed a greater overall morbidity, no differences were found regarding major postoperative complications such as anastomotic leakage or the need for reoperation.
It is worth noting that the mean serum albumin level in both groups was above 4 g/dl, and in most of the studies conducted to assess the relationship between serum albumin and morbidity the cut-off for serum albumin was established at < 3.5 g/dl. This could explain why the statistically significant differences in serum albumin levels had no major clinical implications. On the other hand, lower levels of preoperative serum albumin have been associated with a higher cancer-related mortality and a lower overall survival in patients with colorectal cancer and other malignancies (15, 17, (22) (23) (24) (25) . Therefore, the differences in serum albumin may have long-term implications which are not reflected in this study.
Another finding of the present study related with short-term postoperative outcomes is the assessment of the surgical risk. The percentage of patients with low ASA I-II scores was greater in the screening group. Moreover, the age-adjusted Charlson comorbidity index score was lower in the screening group. Although the difference did not reach statistical significance. In this regard, several studies have demonstrated that both the ASA status and the comorbidities are associated with early postoperative outcomes (19, (26) (27) (28) (29) .
One of the limitations of the present study is the higher percentage of patients with rectal cancer in the control group, which could create a bias and have a direct influence on the results (19, 28) . For this reason, an analysis that excluded patients undergoing low anterior resection or abdominoperineal excision of the rectum was conducted, and statistically significant differences in the preoperative hemoglobin and albumin levels, need for transfusion, overall morbidity and hospital stay were also found. With regard to major postoperative complications, there were no differences in paralytic ileus, anastomotic leakage or reoperation. In the multivariate analysis, surgery for rectal cancer was not an independent factor for the occurrence of complications.
Further studies with larger cohorts are needed to demonstrate whether screening programs are also associated with a reduction of major complications in patients undergoing colorectal cancer surgery.
CONCLUSIONS
In this retrospective cohort of patients, diagnosis of colorectal cancer via the screening program was associated with a lower rate of minor complications and a shorter hospital stay. These differences maintained when only patients with colon cancer were analyzed. The decrease in morbidity was mainly due to a lower percentage of grade II Clavien-Dindo complications. 
